The vast majority of pharmacies in the United States get their drugs delivered through pharmaceutical wholesalers, not directly from manufacturers. About 92 percent of prescription drugs move through these middlemen, who buy in bulk from hundreds of manufacturers, store the products in massive distribution centers, and ship them out to pharmacies on a daily or near-daily basis. Three companies handle over 90 percent of that wholesale volume: McKesson, AmerisourceBergen, and Cardinal Health.
The Big Three Wholesalers
McKesson, AmerisourceBergen, and Cardinal Health operate as the backbone of the U.S. drug supply chain. They purchase medications from manufacturers, warehouse them regionally, and distribute to chain pharmacies, independent pharmacies, hospitals, clinics, nursing homes, and mail-order pharmacies. Their dominance gives them significant leverage, particularly with generic drug manufacturers who compete against each other for contracts with these three companies. That dynamic effectively puts wholesalers in a position to influence generic drug pricing.
Specialty drugs, which include complex biologics and high-cost treatments, now account for more than 30 percent of these wholesalers’ revenue. All three companies have acquired specialty drug distributors over the years to capture more of that market, driven by the high price tags attached to many specialty medications.
How Pharmacies Place Orders
Most pharmacies today use Electronic Data Interchange, or EDI, to order their inventory. This system lets the pharmacy’s own software communicate directly with the wholesaler’s system. A pharmacist can look up a product, check the price, and submit the purchase order without ever picking up a phone, sending a fax, or logging into a separate website. The order goes straight to the wholesaler’s system and processing begins immediately.
Before EDI became standard, the process was slower and more fragmented. A pharmacist would call or fax a supplier, wait for an invoice, pay, and only then would the order ship. Some pharmacists would have to check multiple supplier websites to compare prices and availability. EDI collapsed all of those steps into a single workflow inside the pharmacy’s existing software.
The real power of EDI shows up in inventory management. When a shipment arrives, the new stock is automatically logged in the pharmacy’s system, so the pharmacist always has an accurate count without manual data entry. The system can also be set to auto-reorder products when stock drops below a certain threshold, ensuring the pharmacy doesn’t run out before the next delivery arrives. This lets pharmacies keep smaller quantities on their shelves, reducing storage costs while still having what patients need. It’s essentially a just-in-time inventory model adapted for healthcare.
What Happens Inside the Distribution Center
Pharmaceutical distribution centers are heavily automated. These facilities process enormous volumes of individual products every day and rely on robotics and computer vision to maintain accuracy. Automated systems separate individual items and scan them from all six sides, verifying each product before it’s packed. High-speed conveyor systems with automated ejectors fill orders for fast-moving products, while robotic picking stations handle items that require more precision.
The error rates are remarkably low. One automated picking system documented an error rate of just 0.00083 percent across 960,000 items. AI-powered vision systems and sorting algorithms help identify products and optimize how orders are sequenced and packed. Shuttle storage systems and pocket sorters allow these centers to handle massive surges in order volume, like those that occur during flu season or when a new drug launches, without sacrificing speed or accuracy.
Once packed, orders are loaded onto trucks for delivery. Most retail pharmacies receive shipments once a day, typically overnight or early morning, so the shelves are restocked before the pharmacy opens. Hospitals and high-volume pharmacies may receive multiple deliveries per day.
Tracking Drugs Through the Supply Chain
Federal law requires that prescription drugs be traceable at every step from manufacturer to pharmacy. The Drug Supply Chain Security Act, known as DSCSA, lays out a framework for an interoperable electronic system that identifies and traces prescription drugs at the package level as they move through the supply chain. The goal is to prevent counterfeit or harmful drugs from reaching patients, detect them quickly if they do enter the supply chain, and enable rapid removal.
In practice, this means every time a drug changes hands, from manufacturer to wholesaler to pharmacy, that transaction is documented electronically. Each package carries a unique product identifier that can be verified at every point in the chain. If a recall happens or a counterfeit product is detected, the system allows regulators and companies to pinpoint exactly which packages are affected and where they ended up.
Extra Security for Controlled Substances
Drugs classified as controlled substances, particularly those in the most restricted categories like certain opioids and stimulants, follow stricter delivery protocols. The DEA requires that anyone shipping controlled substances select carriers that provide adequate security against in-transit losses. Shipping containers cannot indicate that their contents are controlled substances, a precaution designed to reduce the risk of theft.
If a controlled substance shipment goes missing or is stolen during transit, the supplier must report the loss to the DEA within one business day of discovering it. When a central fill pharmacy ships completed prescriptions to a retail pharmacy for patient pickup, both the sending and receiving pharmacies are responsible for choosing secure carriers and reporting any losses using a specific DEA form.
Once controlled substances arrive at the pharmacy, storage requirements are strict. Schedule I and II drugs must be kept in a safe or steel cabinet that meets specific resistance standards against forced entry, lock manipulation, and other breach techniques. If the safe weighs less than 750 pounds, it must be bolted or cemented to the floor or wall so it can’t be removed.
How Pricing Works Between Wholesaler and Pharmacy
The starting point for drug pricing in this chain is the wholesale acquisition cost, or WAC. This is essentially the manufacturer’s list price to wholesalers and other direct purchasers. But WAC doesn’t reflect the actual price anyone pays, because it excludes the discounts, rebates, and other incentives that manufacturers routinely offer. The real transaction price between a manufacturer and a wholesaler is typically lower than WAC, though by how much varies widely depending on the drug and the negotiating power of the buyer.
Wholesalers then add their own markup when selling to pharmacies, though margins in wholesale distribution are thin. Much of the wholesalers’ profit on generic drugs comes from their ability to negotiate steep discounts from manufacturers and then sell to pharmacies at a price that still undercuts competitors. For brand-name drugs, wholesalers typically earn a small percentage fee on each transaction rather than a large markup.
Direct-From-Manufacturer Deliveries
While wholesalers handle the bulk of distribution, some drugs bypass them entirely. Certain specialty medications and biologics that require cold chain storage or other special handling are shipped directly from the manufacturer or through a limited network of specialty pharmacies. Some manufacturers also use “buy and bill” arrangements with hospitals and clinics, where the provider purchases the drug directly and administers it to the patient on-site. These direct channels account for a small share of overall prescription volume but are growing as specialty drugs become a larger part of the market.